Nuclear Magnetic Resonance Metabolic Fingerprint of Bevacizumab in Mutant IDH1 Glioma Cells

BACKGROUND: Malignant gliomas are rapidly growing tumours that extensively invade the brain and have bad prognosis. Our study was performed to assess the metabolic effects of bevacizumab on the glioma cells carrying the IDH1 mutation, a mutation, associated with better prognosis and treatment outcom...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Radiol Oncol
Main Authors: Mesti, Tanja, Bouchemal, Nadia, Banissi, Claire, Triba, Mohamed N., Marbeuf-Gueye, Carole, Cemazar, Maja, Moyec, Laurence Le, Carpentier, Antoine F., Savarin, Philippe, Ocvirk, Janja
Format: Artigo
Jezik:Inglês
Izdano: Sciendo 2018
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6287186/
https://ncbi.nlm.nih.gov/pubmed/30511933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2018-0046
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki